+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Syphilis Testing Market By Type, By Location of Testing: Global Opportunity Analysis and Industry Forecast, 2020-2030

  • PDF Icon

    Report

  • 200 Pages
  • April 2022
  • Region: Global
  • Allied Market Research
  • ID: 5640623
Description Jump to:
The syphilis testing market was valued at $ 1,125.1 million in 2020, and is projected to reach $ 1,935.8 million by 2030, registering a CAGR of 5.6 % from 2021 to 2030.

Syphilis is an infectious condition, usually spread by sexual contact. The disease starts as a painless sore on the genitals, rectum, or mouth. The mode of transmission of the disease is person to person via skin or mucous membrane contact. There are two types of tests that are performed for the detection and screening of diseases, such as the treponemal test and non-treponemal tests. The non treponemal test includes, the Treponema pallidum particle agglutination (TP-PA) and fluorescent treponemal antibody (FTA-ABS). The non treponemal test includes, Venereal Disease Research Laboratory (VDRL), which is a laboratory-based test performed for the disease screening. The tests are performed to protect the health of a sexual partner and helps the spread of the disease. It also helps to protect fertility and provides protection to the unborn baby from the infection.

Increase in prevalence of sexually transmitted disease, growth in incidences of sexual contact, and technological advancements in syphilis testing drive the growth of the syphilis testing market. In addition, the rise in geriatric population globally boosts the market growth. Lack of healthcare insurance and less awareness among individuals regarding the benefits of tests declines the growth of market. Higher adoption rates for technologically advanced screening tests, active measures from the governments and private associations, and growing awareness for the syphilis infections largely contribute to the growth of the market.

The syphilis test market is segmented on the basis of type, location of testing and geography. On the basis of type, the market is segmented into primary and secondary syphilis testing. On the basis of location of testing, the market is segmented into laboratory testing & point of care. Geographically, the market is segmented into North America, Europe, Asia-Pacific, and LAMEA.

The major players in the syphilis testing market are focusing on technological advancements in developing syphilis testing products along with complementary service portfolios. Some of the key companies profiled in the report are Roche Diagnostics, Hologic, Inc., Becton Dickinson & Company, Abbott Laboratories, BioMerieux, Astam Diagnostic, Cepheid Inc., Affymetrix, Inc., and Diasorin

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cosmetic surgery market analysis from 2021 to 2031 to identify the prevailingcosmetic surgery market opportunity.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the cosmetic surgery market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global cosmetic surgery market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments


By Type

  • Primary Secondary Syphilis
  • Others

By Location of Testing

  • Laboratory testing
  • Point of care (POC) testing

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia

Key Market Players

  • Hologic, Inc.
  • Becton Dickinson And Company
  • Cepheid Inc.
  • Abbott Laboratories
  • DiaSorin
  • beckman coulter
  • Bio-Rad Laboratories
  • F. Hoffmann-La Roche
  • siemens healthcare
  • Affymetrix, Inc

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market
CHAPTER 4: SYPHILIS TESTING MARKET, BY TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Primary & Secondary Syphilis
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Others
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
CHAPTER 5: SYPHILIS TESTING MARKET, BY LOCATION OF TESTING
5.1 Overview
5.1.1 Market size and forecast
5.2 Laboratory testing
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Point of care (POC) testing
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
CHAPTER 6: SYPHILIS TESTING MARKET, BY REGION
6.1 Overview
6.1.1 Market size and forecast
6.2 North America
6.2.1 Key trends and opportunities
6.2.2 North America Market size and forecast, by Type
6.2.3 North America Market size and forecast, by Location of Testing
6.2.4 North America Market size and forecast, by country
6.2.4.1 U.S.
6.2.4.1.1 Market size and forecast, by Type
6.2.4.1.2 Market size and forecast, by Location of Testing
6.2.4.2 Canada
6.2.4.2.1 Market size and forecast, by Type
6.2.4.2.2 Market size and forecast, by Location of Testing
6.2.4.3 Mexico
6.2.4.3.1 Market size and forecast, by Type
6.2.4.3.2 Market size and forecast, by Location of Testing
6.3 Europe
6.3.1 Key trends and opportunities
6.3.2 Europe Market size and forecast, by Type
6.3.3 Europe Market size and forecast, by Location of Testing
6.3.4 Europe Market size and forecast, by country
6.3.4.1 Germany
6.3.4.1.1 Market size and forecast, by Type
6.3.4.1.2 Market size and forecast, by Location of Testing
6.3.4.2 France
6.3.4.2.1 Market size and forecast, by Type
6.3.4.2.2 Market size and forecast, by Location of Testing
6.3.4.3 U.K.
6.3.4.3.1 Market size and forecast, by Type
6.3.4.3.2 Market size and forecast, by Location of Testing
6.3.4.4 Italy
6.3.4.4.1 Market size and forecast, by Type
6.3.4.4.2 Market size and forecast, by Location of Testing
6.3.4.5 Rest of Europe
6.3.4.5.1 Market size and forecast, by Type
6.3.4.5.2 Market size and forecast, by Location of Testing
6.4 Asia-Pacific
6.4.1 Key trends and opportunities
6.4.2 Asia-Pacific Market size and forecast, by Type
6.4.3 Asia-Pacific Market size and forecast, by Location of Testing
6.4.4 Asia-Pacific Market size and forecast, by country
6.4.4.1 Japan
6.4.4.1.1 Market size and forecast, by Type
6.4.4.1.2 Market size and forecast, by Location of Testing
6.4.4.2 China
6.4.4.2.1 Market size and forecast, by Type
6.4.4.2.2 Market size and forecast, by Location of Testing
6.4.4.3 India
6.4.4.3.1 Market size and forecast, by Type
6.4.4.3.2 Market size and forecast, by Location of Testing
6.4.4.4 Rest of Asia-Pacific
6.4.4.4.1 Market size and forecast, by Type
6.4.4.4.2 Market size and forecast, by Location of Testing
6.5 LAMEA
6.5.1 Key trends and opportunities
6.5.2 LAMEA Market size and forecast, by Type
6.5.3 LAMEA Market size and forecast, by Location of Testing
6.5.4 LAMEA Market size and forecast, by country
6.5.4.1 Brazil
6.5.4.1.1 Market size and forecast, by Type
6.5.4.1.2 Market size and forecast, by Location of Testing
6.5.4.2 Saudi Arabia
6.5.4.2.1 Market size and forecast, by Type
6.5.4.2.2 Market size and forecast, by Location of Testing
CHAPTER 7: COMPANY LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Key developments
CHAPTER 8: COMPANY PROFILES
8.1 Hologic, Inc.
8.1.1 Company overview
8.1.2 Company snapshot
8.1.3 Operating business segments
8.1.4 Product portfolio
8.1.5 Business performance
8.1.6 Key strategic moves and developments
8.2 Becton Dickinson And Company
8.2.1 Company overview
8.2.2 Company snapshot
8.2.3 Operating business segments
8.2.4 Product portfolio
8.2.5 Business performance
8.2.6 Key strategic moves and developments
8.3 Cepheid Inc.
8.3.1 Company overview
8.3.2 Company snapshot
8.3.3 Operating business segments
8.3.4 Product portfolio
8.3.5 Business performance
8.3.6 Key strategic moves and developments
8.4 Abbott Laboratories
8.4.1 Company overview
8.4.2 Company snapshot
8.4.3 Operating business segments
8.4.4 Product portfolio
8.4.5 Business performance
8.4.6 Key strategic moves and developments
8.5 DiaSorin
8.5.1 Company overview
8.5.2 Company snapshot
8.5.3 Operating business segments
8.5.4 Product portfolio
8.5.5 Business performance
8.5.6 Key strategic moves and developments
8.6 beckman coulter
8.6.1 Company overview
8.6.2 Company snapshot
8.6.3 Operating business segments
8.6.4 Product portfolio
8.6.5 Business performance
8.6.6 Key strategic moves and developments
8.7 Bio-Rad Laboratories
8.7.1 Company overview
8.7.2 Company snapshot
8.7.3 Operating business segments
8.7.4 Product portfolio
8.7.5 Business performance
8.7.6 Key strategic moves and developments
8.8 F. Hoffmann-La Roche
8.8.1 Company overview
8.8.2 Company snapshot
8.8.3 Operating business segments
8.8.4 Product portfolio
8.8.5 Business performance
8.8.6 Key strategic moves and developments
8.9 siemens healthcare
8.9.1 Company overview
8.9.2 Company snapshot
8.9.3 Operating business segments
8.9.4 Product portfolio
8.9.5 Business performance
8.9.6 Key strategic moves and developments
8.10 Affymetrix, Inc
8.10.1 Company overview
8.10.2 Company snapshot
8.10.3 Operating business segments
8.10.4 Product portfolio
8.10.5 Business performance
8.10.6 Key strategic moves and developments
LIST OF TABLES
Table 1. Global Syphilis Testing Market, by Type, 2020-2030 ($Million)
Table 2. Syphilis Testing Market Size, for Primary & Secondary Syphilis, by Region, 2020-2030 ($Million)
Table 3. Syphilis Testing Market for Primary & Secondary Syphilis, by Country, 2020-2030 ($Million)
Table 4. Syphilis Testing Market Size, for Others, by Region, 2020-2030 ($Million)
Table 5. Syphilis Testing Market for Others, by Country, 2020-2030 ($Million)
Table 6. Global Syphilis Testing Market, by Location of Testing, 2020-2030 ($Million)
Table 7. Syphilis Testing Market Size, for Laboratory Testing, by Region, 2020-2030 ($Million)
Table 8. Syphilis Testing Market for Laboratory Testing, by Country, 2020-2030 ($Million)
Table 9. Syphilis Testing Market Size, for Point of Care (Poc) Testing, by Region, 2020-2030 ($Million)
Table 10. Syphilis Testing Market for Point of Care (Poc) Testing, by Country, 2020-2030 ($Million)
Table 11. Syphilis Testing Market, by Region, 2020-2030 ($Million)
Table 12. North America Syphilis Testing Market, by Type, 2020-2030 ($Million)
Table 13. North America Syphilis Testing Market, by Location of Testing, 2020-2030 ($Million)
Table 14. North America Syphilis Testing Market, by Country, 2020-2030 ($Million)
Table 15. U.S. Syphilis Testing Market, by Type, 2020-2030 ($Million)
Table 16. U.S. Syphilis Testing Market, by Location of Testing, 2020-2030 ($Million)
Table 17. Canada Syphilis Testing Market, by Type, 2020-2030 ($Million)
Table 18. Canada Syphilis Testing Market, by Location of Testing, 2020-2030 ($Million)
Table 19. Mexico Syphilis Testing Market, by Type, 2020-2030 ($Million)
Table 20. Mexico Syphilis Testing Market, by Location of Testing, 2020-2030 ($Million)
Table 21. Europe Syphilis Testing Market, by Type, 2020-2030 ($Million)
Table 22. Europe Syphilis Testing Market, by Location of Testing, 2020-2030 ($Million)
Table 23. Europe Syphilis Testing Market, by Country, 2020-2030 ($Million)
Table 24. Germany Syphilis Testing Market, by Type, 2020-2030 ($Million)
Table 25. Germany Syphilis Testing Market, by Location of Testing, 2020-2030 ($Million)
Table 26. France Syphilis Testing Market, by Type, 2020-2030 ($Million)
Table 27. France Syphilis Testing Market, by Location of Testing, 2020-2030 ($Million)
Table 28. U.K. Syphilis Testing Market, by Type, 2020-2030 ($Million)
Table 29. U.K. Syphilis Testing Market, by Location of Testing, 2020-2030 ($Million)
Table 30. Italy Syphilis Testing Market, by Type, 2020-2030 ($Million)
Table 31. Italy Syphilis Testing Market, by Location of Testing, 2020-2030 ($Million)
Table 32. Rest of Europe Syphilis Testing Market, by Type, 2020-2030 ($Million)
Table 33. Rest of Europe Syphilis Testing Market, by Location of Testing, 2020-2030 ($Million)
Table 34. Asia-Pacific Syphilis Testing Market, by Type, 2020-2030 ($Million)
Table 35. Asia-Pacific Syphilis Testing Market, by Location of Testing, 2020-2030 ($Million)
Table 36. Asia-Pacific Syphilis Testing Market, by Country, 2020-2030 ($Million)
Table 37. Japan Syphilis Testing Market, by Type, 2020-2030 ($Million)
Table 38. Japan Syphilis Testing Market, by Location of Testing, 2020-2030 ($Million)
Table 39. China Syphilis Testing Market, by Type, 2020-2030 ($Million)
Table 40. China Syphilis Testing Market, by Location of Testing, 2020-2030 ($Million)
Table 41. India Syphilis Testing Market, by Type, 2020-2030 ($Million)
Table 42. India Syphilis Testing Market, by Location of Testing, 2020-2030 ($Million)
Table 43. Rest of Asia-Pacific Syphilis Testing Market, by Type, 2020-2030 ($Million)
Table 44. Rest of Asia-Pacific Syphilis Testing Market, by Location of Testing, 2020-2030 ($Million)
Table 45. LAMEA Syphilis Testing Market, by Type, 2020-2030 ($Million)
Table 46. LAMEA Syphilis Testing Market, by Location of Testing, 2020-2030 ($Million)
Table 47. LAMEA Syphilis Testing Market, by Country, 2020-2030 ($Million)
Table 48. Brazil Syphilis Testing Market, by Type, 2020-2030 ($Million)
Table 49. Brazil Syphilis Testing Market, by Location of Testing, 2020-2030 ($Million)
Table 50. Saudi Arabia Syphilis Testing Market, by Type, 2020-2030 ($Million)
Table 51. Saudi Arabia Syphilis Testing Market, by Location of Testing, 2020-2030 ($Million)
Table 52. Hologic, Inc.: Company Snapshot
Table 53. Hologic, Inc.: Operating Segments
Table 54. Hologic, Inc.: Product Portfolio
Table 55. Hologic, Inc.: Net Sales
Table 56. Hologic, Inc.: Key Stratergies
Table 57. Becton Dickinson and Company: Company Snapshot
Table 58. Becton Dickinson and Company: Operating Segments
Table 59. Becton Dickinson and Company: Product Portfolio
Table 60. Becton Dickinson and Company: Net Sales
Table 61. Becton Dickinson and Company: Key Stratergies
Table 62. Cepheid Inc.: Company Snapshot
Table 63. Cepheid Inc.: Operating Segments
Table 64. Cepheid Inc.: Product Portfolio
Table 65. Cepheid Inc.: Net Sales
Table 66. Cepheid Inc.: Key Stratergies
Table 67. Abbott Laboratories: Company Snapshot
Table 68. Abbott Laboratories: Operating Segments
Table 69. Abbott Laboratories: Product Portfolio
Table 70. Abbott Laboratories: Net Sales
Table 71. Abbott Laboratories: Key Stratergies
Table 72. Diasorin: Company Snapshot
Table 73. Diasorin: Operating Segments
Table 74. Diasorin: Product Portfolio
Table 75. Diasorin: Net Sales
Table 76. Diasorin: Key Stratergies
Table 77. Beckman Coulter: Company Snapshot
Table 78. Beckman Coulter: Operating Segments
Table 79. Beckman Coulter: Product Portfolio
Table 80. Beckman Coulter: Net Sales
Table 81. Beckman Coulter: Key Stratergies
Table 82. Bio-Rad Laboratories: Company Snapshot
Table 83. Bio-Rad Laboratories: Operating Segments
Table 84. Bio-Rad Laboratories: Product Portfolio
Table 85. Bio-Rad Laboratories: Net Sales
Table 86. Bio-Rad Laboratories: Key Stratergies
Table 87. F. Hoffmann-La Roche: Company Snapshot
Table 88. F. Hoffmann-La Roche: Operating Segments
Table 89. F. Hoffmann-La Roche: Product Portfolio
Table 90. F. Hoffmann-La Roche: Net Sales
Table 91. F. Hoffmann-La Roche: Key Stratergies
Table 92. Siemens Healthcare: Company Snapshot
Table 93. Siemens Healthcare: Operating Segments
Table 94. Siemens Healthcare: Product Portfolio
Table 95. Siemens Healthcare: Net Sales
Table 96. Siemens Healthcare: Key Stratergies
Table 97. Affymetrix, Inc: Company Snapshot
Table 98. Affymetrix, Inc: Operating Segments
Table 99. Affymetrix, Inc: Product Portfolio
Table 100. Affymetrix, Inc: Net Sales
Table 101. Affymetrix, Inc: Key Stratergies
LIST OF FIGURES
Figure 1. Syphilis Testing Market Segmentation
Figure 2. Syphilis Testing Market, 2020-2030
Figure 3. Syphilis Testing Market, 2020-2030
Figure 4. Top Investment Pockets, by Region
Figure 5. Porter Five-1
Figure 6. Porter Five-2
Figure 7. Porter Five-3
Figure 8. Porter Five-4
Figure 9. Porter Five-5
Figure 10. Top Player Positioning
Figure 11. Syphilis Testing Market:Drivers, Restraints and Opportunities
Figure 12. Syphilis Testing Market, by Type, 2020 (%)
Figure 13. Comparative Share Analysis of Primary & Secondary Syphilis Syphilis Testing Market, 2020-2030 (%)
Figure 14. Comparative Share Analysis of Others Syphilis Testing Market, 2020-2030 (%)
Figure 15. Syphilis Testing Market, by Location of Testing, 2020 (%)
Figure 16. Comparative Share Analysis of Laboratory Testing Syphilis Testing Market, 2020-2030 (%)
Figure 17. Comparative Share Analysis of Point of Care (Poc) Testing Syphilis Testing Market, 2020-2030 (%)
Figure 18. Syphilis Testing Market by Region, 2020
Figure 19. U.S. Syphilis Testing Market, 2020-2030 ($Million)
Figure 20. Canada Syphilis Testing Market, 2020-2030 ($Million)
Figure 21. Mexico Syphilis Testing Market, 2020-2030 ($Million)
Figure 22. Germany Syphilis Testing Market, 2020-2030 ($Million)
Figure 23. France Syphilis Testing Market, 2020-2030 ($Million)
Figure 24. U.K. Syphilis Testing Market, 2020-2030 ($Million)
Figure 25. Italy Syphilis Testing Market, 2020-2030 ($Million)
Figure 26. Rest of Europe Syphilis Testing Market, 2020-2030 ($Million)
Figure 27. Japan Syphilis Testing Market, 2020-2030 ($Million)
Figure 28. China Syphilis Testing Market, 2020-2030 ($Million)
Figure 29. India Syphilis Testing Market, 2020-2030 ($Million)
Figure 30. Rest of Asia-Pacific Syphilis Testing Market, 2020-2030 ($Million)
Figure 31. Brazil Syphilis Testing Market, 2020-2030 ($Million)
Figure 32. Saudi Arabia Syphilis Testing Market, 2020-2030 ($Million)
Figure 33. Top Winning Strategies, by Year
Figure 34. Top Winning Strategies, by Development
Figure 35. Top Winning Strategies, by Company
Figure 36. Product Mapping of Top 10 Players
Figure 37. Competitive Dashboard
Figure 38. Competitive Heatmap of Top 10 Key Players
Figure 39. Hologic, Inc. Net Sales, ($Million)
Figure 40. Becton Dickinson and Company.: Net Sales, ($Million)
Figure 41. Cepheid Inc. Net Sales, ($Million)
Figure 42. Abbott Laboratories.: Net Sales, ($Million)
Figure 43. Diasorin.: Net Sales, ($Million)
Figure 44. Beckman Coulter.: Net Sales, ($Million)
Figure 45. Bio-Rad Laboratories.: Net Sales, ($Million)
Figure 46. F. Hoffmann-La Roche.: Net Sales, ($Million)
Figure 47. Siemens Healthcare.: Net Sales, ($Million)
Figure 48. Affymetrix, Inc.: Net Sales, ($Million)

Executive Summary

According to this report titled, 'Syphilis Testing Market,' the syphilis testing market was valued at $1.1 billion in 2020, and is estimated to reach $1.9 billion by 2030, growing at a CAGR of 5.6% from 2021 to 2030.
Syphilis is a sexually transmitted disease caused by Treponema pallidum bacteria. Syphilis tests are used for screening and detection of antibodies against bacteria into the patients’ blood. There are various complications related to syphilis infection, such as infertility in both, men and women, ectopic pregnancy, cervical cancer in women and congenital mortality, and infections. Treponemal tests applied for the screening of bacterial infection includes the Treponema pallidum particle agglutination (TP-PA) and fluorescent treponemal antibody (FTA-ABS). Non-treponemal tests are relatively simple to perform and interpret, give rapid results, and are economic. However, non-treponemal tests require laboratory equipment and trained personnel to perform and interpret test reactions. Non-treponemal tests include, Rapid Plasma Reagin (RPR), which is an improved version of the Venereal Disease Research Laboratory (VDRL) test and tests for the same antigen.

The key factors that drive the growth of syphilis testing market size are rise in the prevalence of sexually transmitted disease and technological advancements. Moreover, improved healthcare infrastructure, rapid development in diagnostic kits, and availability of test kits are other factors that are expected to create opportunities for market growth during the forecast period. Furthermore, growth in incidences of diseases such as sexually transmitted disease, including syphilis has positively propelled the growth of the global syphilis testing market share. There are increasing incidences of the condition being transmitted by and among MSM (Men who have sex with men) population, injecting drug users, and sex workers. Syphilis constitutes a high proportion of health and economic burden for the developing countries. Especially, visits to the specialized STD clinics are noticed and to avoid uncomfortable situations or embarrassment in the society, many refrain from voluntary/CICT Syphilis testing at any of the labs or STD clinics. This hinders the uptake of diagnostic tests or testing volume, thus restraining the growth of the syphilis testing market.

The syphilis testing market analysis is segmented on the basis of type, location of testing and geography. On the basis of type, the syphilis testing market growth is segmented into primary and secondary syphilis testing. On the basis of location of testing, the market is segmented into laboratory testing & point of care. Geographically, the market is segmented into North America, Europe, Asia-Pacific, and LAMEA.

By type, the syphilis testing market forecast is segment into primary and secondary syphilis testing market. The secondary syphilis segment holds the largest market share whereas the primary syphilis segment is estimated to witness the highest CAGR during the forecast period.

By location of testing, the syphilis testing industry is segmented into laboratory testing & point of care. The laboratory test segment is a highest market contributor in 2020. As laboratory testing is cost efficient, convenient and confidential the laboratory testing segment dominated the market in 2020 and is expected to continue this trend during the forecast period.

By region, the syphilis testing industry is analyzed across North America, Asia-Pacific, Europe, and LAMEA. LAMEA dominated the market in 2020, accounting for the highest share, and is anticipated to maintain this trend during the forecast period. The prevalence and incidence rates of syphilis, typically have higher laboratory testing costs in LAMEA than in Asia-Pacific.

KEY FINDINGS OF STUDY

  • By type, the secondary syphilis testing segment was the highest contributor to the market in 2020.
  • By location of testing, the laboratory test segment was the highest contributor to the market in 2020.
  • Region-wise, North America is the largest revenue share in 2020. However, Europe is anticipated to grow at the highest CAGR during the forecast period.

Companies Mentioned

  • Hologic, Inc.
  • Becton Dickinson And Company
  • Cepheid Inc.
  • Abbott Laboratories
  • DiaSorin
  • beckman coulter
  • Bio-Rad Laboratories
  • F. Hoffmann-La Roche
  • siemens healthcare
  • Affymetrix, Inc

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages200
PublishedApril 2022
Forecast Period2020 - 2030
Estimated Market Value ( USD ) in 2020 $ 1125.1 million
Forecasted Market Value ( USD ) by 2030 $ 1935.8 million
Compound Annual Growth Rate5.6%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Syphilis Testing Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Syphilis Testing Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 90 Pages
  • Global
From
Syphilis Testing Market by Type, Location of Testing, and Region 2024-2032 - Product Image

Syphilis Testing Market by Type, Location of Testing, and Region 2024-2032

  • Report
  • 137 Pages
  • Global
From
2024-2028 Global Syphilis Testing in 90 Countries: Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation - Product Image

2024-2028 Global Syphilis Testing in 90 Countries: Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

  • Report
  • Global
From
Syphilis Immunoassay Diagnostic Market by Product, Technology, End User - Global Forecast 2025-2030 - Product Image

Syphilis Immunoassay Diagnostic Market by Product, Technology, End User - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
STD Testing - Global Strategic Business Report - Product Image

STD Testing - Global Strategic Business Report

  • Report
  • 197 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.